The action of the pharmacist in front of bacterial resistance and rational use of antimicrobials in the hospital environment
DOI:
https://doi.org/10.33448/rsd-v12i6.42037Keywords:
Antimicrobials; Bacterial resistance to antibiotics; Hospital assistance; Pharmaceutical.Abstract
Antimicrobials are one of the best discoveries of the 20th century, which concomitant with their use came one of the biggest current problems in the world, bacterial resistance. Within this context, the present study aims to highlight the role of the pharmacist in the face of bacterial resistance and rational use of antimicrobials in the hospital environment. For the development of the study, a literature review was carried out for a reflective analysis based on studies published from 2010 to 2022 in the main databases found in Portuguese, English and Spanish. We selected 20 articles out of 6,650 found before applying the inclusion and exclusion criteria and performing the analysis. The clinical pharmacist plays a key role in combating bacterial resistance. In addition, the hospital environment is a place where there are more people in the same environment administering various antibiotics and different spectrums. The pharmaceutical professional has a direct and indirect impact on patients and medicines, being responsible for promoting the rational use of antibiotics, with standardization of medicines and possible interventions in the treatment, providing care, insurance, and health to the patient. Therefore, it is an important key in combating bacterial resistance, which is a public health issue, in addition to the possibility of promoting research and innovation in the field of microbiology and antimicrobial therapy.
References
Abbas, A. K., Lichtman, A. H., & Pillai, S. (2023). Imunologia Celular e Molecular. 10ª ed. Rio de Janeiro: Elsevier.
Brasil. (2013). Resolução Nº 585. Conselho. Regional de Farmácia. Available in: https://www.cff.org.br/userfiles/file/resolucoes/585.pdf. Accessed on June 04 of 2023.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. (2018). Plano de ação nacional de prevenção e controle da resistência aos antimicrobianos no âmbito da saúde única 2018-2022 (PAN-BR) / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. – Brasília: Ministério da Saúde. Available in: https://bvsms.saude.gov.br/bvs/publicacoes/plano_prevencao_resistencia_antimicrobianos.pdf. Accessed on June 04 of 2023.
Bush, K., & Bradford, P. A. (2016). β-Lactams and β-Lactamase Inhibitors: An Overview. Cold Spring Harbor perspectives in medicine, 6(8), a025247.
Davies J, & Davies D. (2010). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 74 (3): 417-33. doi: 10.1128/MMBR.00016-10. PMID: 20805405; PMCID: PMC2937522.
Donizete, A. L., Oliveira, J. de, Romeiro, J. R., & Moreno, A. H. (2020). Importance of the rational use of medicines in the administration of injectable antibiotic therapy. CuidArte, Enfermagem, 14(2): 226-232.
Fleming A. (1929). On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. British Journal of Experimental Pathology, 10(3):226-236.
Fleming, A. (1945). Penicillin. Nobel Lecture. Disponível em: https://www.nobelprize.org/prizes/medicine/1945/fleming/lecture/. Acesso em 05 de maio de 2023.
Hasan, C. M., Dutta, D., & Nguyen, A. N. T. (2021). Revisiting Antibiotic Resistance: Mechanistic Foundations to Evolutionary Outlook. Antibiotics (Basel, Switzerland), 11(1), 40. https://doi.org/10.3390/antibiotics11010040
Hooper D. C. (2000). Mechanisms of action and resistance of older and newer fluoroquinolones. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 31 Suppl 2, S24–S28. https://doi.org/10.1086/314056
Infectious Diseases Society of America (IDSA), Spellberg, B., Blaser, M., Guidos, R. J., Boucher, H. W., Bradley, J. S., Eisenstein, B. I., Gerding, D., Lynfield, R., Reller, L. B., Rex, J., Schwartz, D., Septimus, E., Tenover, F. C., & Gilbert, D. N. (2011). Combating antimicrobial resistance: policy recommendations to save lives. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 52 Suppl 5(Suppl 5), S397–S428.
Iversen, V. M., Vasseljen, O., Mork, P. J., & Fimland, M. S. (2018). Resistance training vs general physical exercise in multidisciplinary rehabilitation of chronic neck pain: A randomized controlled trial. Journal of rehabilitation medicine, 50(8), 743–750.
Kannebley Júnior, S. et al. (2020). Implantação da administração de antimicrobianos gerenciada por farmacêuticos em hospital de ensino: impacto na redução do consumo de antibióticos e no controle de patógenos multirresistentes. Revista de Ciências Farmacêuticas Básica e Aplicada, v. 41, n. 4, p. 1-7.
Larsson, D.G.J., & Flach, C.F. (2022). Antibiotic resistance in the environment. Nature Reviews Microbiology. 20, 257–269.
Li, X-Z.; Elkins, C. A. & Zgurskaya H. I. (2016). Efflux-Mediated Antimicrobial Resistance in Bacteria: Mechanisms, Regulation and Clinical Implications. Springer, 6(7), a025317.
Mazzillo Vega, Liliana, & Cabrera Bravo, Nancy. (2020). Uso racional de antibióticos y tecnología FilmArray para identificación rápida de bacteriemias en unidad de cuidados intensivos pediátrica. Revista Chilena de Pediatría, 91(4), 553-560.
Mello, M. S. de., & Oliveira, A. C. (2021). Overview of the actions to combat bacterial resistance in large hospitals. Revista Latino-americana De Enfermagem, 29, e3407.
Miranda, L. R, Benvenuti, P. R., & Leão, N. M. L. (2022). O uso de antibióticos e o papel do farmacêutico clínico no combate a resistência bacteriana. Revista Cereus, 14 (3).
Mitrel, G. S., Silva, S. A. B., Silva, G. A. B., Rezende, M. M. D. P., & Sousa Júnior, J. R. (2017). Perfil de prescrição de antimicrobianos nas unidades básicas de saúde conveniadas com a universidade de Itaúna/MG. Revista Médica de Minas Gerais, v. 27, n. e-1875.
Mota, L.M., Vilar, F. C., Dias, L. B. A., Nunes, T. F., & Moriguti J. C. (2010). Uso racional de antimicrobianos. Medicina (Ribeirão Preto) [Internet] 43(2):164-72.
Munita, J. M., & Arias, C. A. (2016). Mechanisms of Antibiotic Resistance. Microbiology spectrum, 4(2), 10.1128/microbiolspec.VMBF-0016-2015.
Pereira, E. da S., Jesus, G. de A. C., Souza, L. D. B. de, & Carneiro, V. M. S. (2022). The importance of the pharmacist in hospital infection control: integrative review. Research, Society and Development, 11(15), e573111537616.
Santos Nogueira, H., Ericsson de Oliveira Xavier, A. R., De Sousa Xavier, M. A., Amaral Carvalho, A., Ataíde Monção, G., & Prates Barreto, N. A. (2020). Antibacterianos: Principais classes, mecanismos de ação e resistência. Revista Unimontes Científica, [S. l.], v. 18, n. 2, p. 96–108.
Santos, S. L. F., Pessoa, C. V., Alves, H. H. da S., & Borges, R. N. (2017). Papel do farmacêutico no uso racional de antibióticos. RSC online 6(1): p. 79 - 88.
Sosa-Hernández, O., Vázquez-Zamora, C., Gutiérrez-Muñoz, V. H., Lugo-Zamudio, G. E., & Cureño-Díaz, M. A. (2020). Resultados del Programa de Uso Racional de Antimicrobianos en un hospital de México, 2013-2018 [Results of the Program for the Rational Use of Antimicrobials in a Mexican hospital, 2013-2018Resultados de um programa para o uso racional de antimicrobianos num hospital no México, 2013-2018]. Revista panamericana de salud publica = Pan American journal of public health, 44, e45.
Souza, J., Dias, F. R., & Alvim, H. G. De O. Resistência bacteriana aos antibióticos. Revista JRG de Estudos Acadêmicos, Brasil, São Paulo, v. 5, n. 10, p. 281–293, 2022.
Teixeira, A. R., Figueiredo, A. F. C., & França, R. F. (2020). Resistencia bacteriana relacionada ao uso indiscriminado de antibióticos. Revista Saúde em Foco 11: 853-875.
Who. World Health Organization. (2015). Global action plan on antimicrobial resistance. Genebra: WHO Press.
Who. World Health Organization. (2019). Antimicrobial stewardship programmes in health-care facilities in low-and middle-income countries: a WHO practical toolkit.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Brenda Caroline de Araújo Lima; Emily dos Santos Silva; Robson de Jesus; Emilly Anny Benevides de Abreu; Fabiana Chagas Oliveira de França; Aranin Queiroz de Sousa Santos; José Alfredo de Oliveira Alkmin; Anderson dos Santos Barbosa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
